Birdwatch Note
2023-12-02 15:32:24 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
タチオン錠は薬物中毒、アセトン血性嘔吐症（自家中毒、周期性嘔吐症）、金属中毒、妊娠悪阻、妊娠高血圧症候群のための薬で、 https://www.carenet.com/drugs/category/antidotes/3922001F2248 ユベラは ビタミンＥ欠乏症の予防及び治療。末梢循環障害（間欠性跛行症、動脈硬化症、静脈血栓症、血栓性静脈炎、糖尿病性網膜症、凍瘡、四肢冷感症）。また上記以外の効能については、効果がないのに月余にわたって漫然と使用すべきではない https://www.carenet.com/drugs/category/vitamin-e-preparations/3150002F1239 などなど、本来と違う用途を喧伝しており、またそのように薬を使う事は危険であること。 また医者以外が医療行為を行うことは医師法17条に違反する可能性があります https://www.gslaw.jp/columns-corporate/practice/
Written by 4AA0572B438759AD1F3E00928F482AF11F32B27C2DE62E69755DD0D9AB4CBA92
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1730578618626277473
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1730973195828933030
- noteId - 1730973195828933030
- participantId -
- noteAuthorParticipantId - 4AA0572B438759AD1F3E00928F482AF11F32B27C2DE62E69755DD0D9AB4CBA92 Participant Details
- createdAtMillis - 1701531144469
- tweetId - 1730578618626277473
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 1
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 0
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- タチオン錠は薬物中毒、アセトン血性嘔吐症（自家中毒、周期性嘔吐症）、金属中毒、妊娠悪阻、妊娠高血圧症候群のための薬で、 https://www.carenet.com/drugs/category/antidotes/3922001F2248 ユベラは ビタミンＥ欠乏症の予防及び治療。末梢循環障害（間欠性跛行症、動脈硬化症、静脈血栓症、血栓性静脈炎、糖尿病性網膜症、凍瘡、四肢冷感症）。また上記以外の効能については、効果がないのに月余にわたって漫然と使用すべきではない https://www.carenet.com/drugs/category/vitamin-e-preparations/3150002F1239 などなど、本来と違う用途を喧伝しており、またそのように薬を使う事は危険であること。 また医者以外が医療行為を行うことは医師法17条に違反する可能性があります https://www.gslaw.jp/columns-corporate/practice/
Note Status History
| createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
| 2023-12-02 15:32:24 UTC (1701531144469) |
2023-12-02 18:03:56 UTC (1701540236303) |
CURRENTLY_RATED_HELPFUL | 2023-12-03 04:27:56 UTC (1701577676238) |
CURRENTLY_RATED_HELPFUL | 2023-12-02 18:03:56 UTC (1701540236303) |
CURRENTLY_RATED_HELPFUL |
Note Ratings
| rated at | rated by | |
| 2023-12-02 18:39:19 -0600 | Rating Details | |
| 2023-12-02 16:07:11 -0600 | Rating Details | |
| 2023-12-02 12:24:02 -0600 | Rating Details | |
| 2023-12-02 12:08:15 -0600 | Rating Details | |
| 2023-12-02 11:56:26 -0600 | Rating Details | |
| 2023-12-02 11:50:53 -0600 | Rating Details | |
| 2023-12-02 11:50:46 -0600 | Rating Details | |
| 2023-12-02 11:50:14 -0600 | Rating Details | |
| 2023-12-02 11:37:16 -0600 | Rating Details | |
| 2023-12-02 11:36:01 -0600 | Rating Details | |
| 2023-12-02 11:31:52 -0600 | Rating Details | |
| 2023-12-02 11:29:01 -0600 | Rating Details | |
| 2023-12-02 11:26:26 -0600 | Rating Details | |
| 2023-12-02 11:18:56 -0600 | Rating Details | |
| 2023-12-02 11:12:18 -0600 | Rating Details | |
| 2023-12-02 11:11:08 -0600 | Rating Details | |
| 2023-12-02 11:06:00 -0600 | Rating Details | |
| 2023-12-02 10:56:04 -0600 | Rating Details | |
| 2023-12-02 10:43:36 -0600 | Rating Details | |
| 2023-12-02 10:41:52 -0600 | Rating Details | |
| 2023-12-02 10:27:19 -0600 | Rating Details | |
| 2023-12-02 10:26:12 -0600 | Rating Details | |
| 2023-12-02 10:23:19 -0600 | Rating Details | |
| 2023-12-02 10:22:55 -0600 | Rating Details | |
| 2023-12-02 10:22:44 -0600 | Rating Details | |
| 2023-12-02 10:14:15 -0600 | Rating Details | |
| 2023-12-02 10:12:11 -0600 | Rating Details | |
| 2023-12-02 10:09:49 -0600 | Rating Details | |
| 2023-12-02 10:09:29 -0600 | Rating Details | |
| 2023-12-02 10:09:14 -0600 | Rating Details | |
| 2023-12-02 10:04:02 -0600 | Rating Details | |
| 2023-12-02 10:03:58 -0600 | Rating Details | |
| 2023-12-02 10:01:21 -0600 | Rating Details | |
| 2023-12-02 10:01:10 -0600 | Rating Details | |
| 2023-12-02 09:58:29 -0600 | Rating Details | |
| 2023-12-02 09:55:37 -0600 | Rating Details | |
| 2023-12-02 09:52:40 -0600 | Rating Details | |
| 2023-12-02 09:51:55 -0600 | Rating Details | |
| 2023-12-02 09:48:21 -0600 | Rating Details | |
| 2023-12-02 09:46:45 -0600 | Rating Details | |
| 2023-12-02 09:45:18 -0600 | Rating Details | |
| 2023-12-02 09:45:07 -0600 | Rating Details | |
| 2023-12-02 09:44:36 -0600 | Rating Details | |
| 2023-12-02 09:44:25 -0600 | Rating Details | |
| 2023-12-02 09:42:02 -0600 | Rating Details | |
| 2023-12-02 09:41:13 -0600 | Rating Details | |
| 2023-12-02 09:40:52 -0600 | Rating Details | |
| 2023-12-02 09:39:29 -0600 | Rating Details | |
| 2023-12-02 09:37:07 -0600 | Rating Details | |
| 2023-12-03 20:17:37 -0600 | Rating Details | |
| 2023-12-02 15:37:08 -0600 | Rating Details | |
| 2023-12-02 14:27:19 -0600 | Rating Details | |
| 2023-12-02 13:55:39 -0600 | Rating Details | |
| 2023-12-02 13:40:54 -0600 | Rating Details | |
| 2023-12-02 13:02:29 -0600 | Rating Details | |
| 2023-12-02 12:16:02 -0600 | Rating Details | |
| 2023-12-02 12:15:11 -0600 | Rating Details | |
| 2023-12-02 12:10:17 -0600 | Rating Details | |
| 2023-12-02 11:57:57 -0600 | Rating Details | |
| 2023-12-02 11:51:40 -0600 | Rating Details | |
| 2023-12-02 11:42:55 -0600 | Rating Details | |
| 2023-12-02 11:42:22 -0600 | Rating Details | |
| 2023-12-02 11:34:28 -0600 | Rating Details | |
| 2023-12-02 11:16:07 -0600 | Rating Details | |
| 2023-12-02 11:15:58 -0600 | Rating Details | |
| 2023-12-02 11:12:09 -0600 | Rating Details | |
| 2023-12-02 11:06:50 -0600 | Rating Details | |
| 2023-12-02 11:04:35 -0600 | Rating Details | |
| 2023-12-02 11:01:54 -0600 | Rating Details | |
| 2023-12-02 11:01:35 -0600 | Rating Details | |
| 2023-12-02 10:56:03 -0600 | Rating Details | |
| 2023-12-02 10:45:18 -0600 | Rating Details | |
| 2023-12-02 10:44:24 -0600 | Rating Details | |
| 2023-12-02 10:44:04 -0600 | Rating Details | |
| 2023-12-02 10:43:39 -0600 | Rating Details | |
| 2023-12-02 10:41:54 -0600 | Rating Details | |
| 2023-12-02 10:38:42 -0600 | Rating Details | |
| 2023-12-02 10:35:41 -0600 | Rating Details | |
| 2023-12-02 10:33:22 -0600 | Rating Details | |
| 2023-12-02 10:32:56 -0600 | Rating Details | |
| 2023-12-02 10:32:09 -0600 | Rating Details | |
| 2023-12-02 10:23:32 -0600 | Rating Details | |
| 2023-12-02 10:19:38 -0600 | Rating Details | |
| 2023-12-02 10:14:03 -0600 | Rating Details | |
| 2023-12-02 10:12:06 -0600 | Rating Details | |
| 2023-12-02 10:06:56 -0600 | Rating Details | |
| 2023-12-02 10:02:05 -0600 | Rating Details | |
| 2023-12-02 09:52:43 -0600 | Rating Details | |
| 2023-12-02 09:51:12 -0600 | Rating Details | |
| 2023-12-02 09:49:02 -0600 | Rating Details | |
| 2023-12-02 09:48:31 -0600 | Rating Details | |
| 2023-12-02 09:45:59 -0600 | Rating Details | |
| 2023-12-02 09:44:03 -0600 | Rating Details | |
| 2023-12-02 09:43:51 -0600 | Rating Details | |
| 2023-12-02 09:42:06 -0600 | Rating Details | |
| 2023-12-02 09:42:05 -0600 | Rating Details | |
| 2023-12-02 09:40:43 -0600 | Rating Details | |
| 2023-12-02 09:40:17 -0600 | Rating Details | |
| 2023-12-02 09:40:13 -0600 | Rating Details | |
| 2023-12-02 09:39:57 -0600 | Rating Details | |
| 2023-12-02 09:38:11 -0600 | Rating Details | |
| 2023-12-02 09:37:32 -0600 | Rating Details | |
| 2023-12-02 09:36:16 -0600 | Rating Details | |
| 2023-12-02 09:35:37 -0600 | Rating Details | |
| 2023-12-02 09:34:21 -0600 | Rating Details | |
| 2023-12-05 17:27:33 -0600 | Rating Details | |
| 2023-12-02 10:07:01 -0600 | Rating Details |